A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Clinical trial NCT06937749 · RECRUITING
Trial details
- NCT number
- NCT06937749
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2026-04-30
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.